Mixing meds

25 September 2006 By John Foley

The race to consolidate is clearly on. The Belgian group is the third midsized European drugs group to buy a rival in the past week. What has unblocked the dam? It s that the sellers have all dropped their prices, perhaps because they are scared of being left on the shelf.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)